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Background: Anxiety, Depression and Somatoform (ADSom) disorders are highly prevalent in primary care. Managing
these disorders is time-consuming and requires strong commitment on behalf of the General Practitioners (GPs).
Furthermore, the management of these patients is restricted by the high patient turnover rates in primary care
practices, especially in the German health care system.
In order to address this problem, we implement a complex, low-threshold intervention by an Advanced Practice Nurse
(APN) using a mixture of case management and counseling techniques to promote self-management in these patients.
Here we present the protocol of the “Self-Management Support for Anxiety, Depression and Somatoform Disorders in
Primary Care” (SMADS)-Study.
Methods/Design: The study is designed as a cluster-randomized controlled trial, comparing an intervention and a
control group of 10 primary care practices in each case. We will compare the effectiveness of the intervention applied
by an APN with usual GP-care. A total of 340 participants will be enrolled in the study, 170 in either arm. We use the
Patient Health Questionnaire-German version (PHQ-D) as a screening tool for psychiatric symptoms, including patients
with a score above 5 on any of the three symptom scales. The primary outcome is self-efficacy, measured by the
General Self-Efficacy Scale (GSE), here used as a proxy for self-management. As secondary outcomes we include the
PHQ-D symptom load and questionnaires regarding coping with illness and health related quality of life. Outcome
assessments will be applied 8 weeks and 12 months after the baseline assessment.
Discussion: The SMADS-study evaluates a complex, low threshold intervention for ambulatory patients presenting
ADSom-symptoms, empowering them to better manage their condition, as well as improving their motivation to
engage in self-help and health-seeking behaviour. The benefit of the intervention will be substantiated, when patients
can enhance their expected self-efficacy, reduce their symptom load and engage in more self-help activities to deal
with their everyday lives. After successfully evaluating this psychosocial intervention, a new health care model for the
management of symptoms of anxiety, depression and somatoform disorders for ambulatory patients could emerge,
supplementing the work of the GP.
Trial registration: Clinicaltrials.gov Identifier: NCT01726387
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nursing careBackground
Anxiety disorders, depression and somatoform disorders
(hereafter referred to as ADSom disorders) belong to the
most common mental disorders in primary care [1].
ADSom disorders contribute to a substantial utilization
of the health care system [2]. Also, ADSom disorders
cause significant direct and indirect health care costs [3].
Mental disorders – an urgent problem in primary health
care
There is no controversy about the pivotal role of primary
care in treating these mental conditions: most patients
with ADSom symptoms are primarily and often ex-
clusively seen by their general practitioner (GP) [4-6]. A
survey conducted by the Bertelsmann Foundation [7] re-
vealed only 13% of patients with psychological complaints
over the past 12 months were seeking solely specialized
care. Moreover, ADSom-disorders are frequently associ-
ated with, or sometimes masked by, somatic disorders,
therefore, an additional somatic medical examination by
the GP is necessary [8]. Not least, the World Health
Organization recommends the integration of mental
health care into primary care. It “enhances access, pro-
motes respect of human rights, is affordable and cost
effective, and generates good health outcomes” [9].
However, targeting the many problems these patients
convey exceeds the resources of most GPs. Also, high
patient turnover rates in primary care inevitably limit
contact time between GP and patients: In Germany, an
average of 18 primary-care-contacts per year per patient
in 2007 [10], even 35–54 contacts per year for multi-
morbid patients [11], render it impossible to discover
and unveil backgrounds and/or motifs of the psycho-
logical symptoms and complaints. Regular consultations
focus mainly on acute care, thus falling too short to en-
hance and support self-management skills of the pa-
tients. Professional self-management support is beyond
the scope of usual GP-care, although self-management
support through patient education and counseling is a
cornerstone of mental health care [12].
The German social security system offers quite a few
different services for patients in psychosocial need: help-
desks, helplines, publicly-funded self-help groups, counsel-
ing services, community based social-psychiatric support,
rehabilitation services, re-integration services after long
sickness leaves, and if nothing else: psychotherapy. Even
though the services are there, more often than not
ADSom-patients are not able to help themselves by takingthe next step - accessing a service. There is paperwork to
do, contacting, networking, information seeking and so on –
tasks patients with psychological complaints have a hard
time executing. Symptoms prevent the utilization of avail-
able services [13]. Finally, there is a lack of coordination
amongst these services as they are offered in an unsystem-
atic and erratic way. Depending on the information they
have, GPs recommend certain services to their patients, but
quite a few are reluctant to get involved in the time-
consuming, usually not reimbursed methods of accessing
these services. In order to supplement patient management,
we introduce a specially trained Advanced Practice Nurse
(APN) working alongside a GP in the practice.
Several trials support this collaborative care model.
Health care assistants helped to reduce patients’ depres-
sive symptoms in the PROMPT-Study [14]. Elderly pa-
tients showed long-term improvement in their depressive
symptomatology in the IMPACT-trial [15]. A program to
manage depression interprofessionally proved to be effect-
ive in the INDI-trial [16].
A recent Cochrane review concludes: “Collaborative
care is associated with significant improvement in depres-
sion and anxiety outcomes compared with usual care, and
represents a useful addition to clinical pathways for adult
patients with depression and anxiety” [17].
In recent years, Germany has begun to gradually change
its legislation to allow health care professionals like APNs
to deliver services for patients. The law now facilitates the
delegation of a wide variety of health services from a GP
to a health care assistant or an APN. In spring 2012 a dir-
ective for the delegation of medicinal work to other health
care professions (“Heilkundeübertragungsrichtlinie”) was
put into action by the Joint Federal Commission, a ruling
body for health care services in Germany [18].
Based on that directive we implement a complex, low-
threshold intervention by an APN using case management
and counseling techniques to support ADSom-patients.
The APNs will help the patients to better understand their
symptoms and complaints, identify stressors and re-
sources, as well as create goals to be attained in the course
of the intervention.
Here we report the study protocol of the “Self-
Management Support for Anxiety, Depression and Soma-
toform Disorders in Primary Care” (SMADS)-Study.
Objective
The objective of the study is to examine the effects of
counseling and case management on the concept of self-
10 Practices Intervention Group 10 Practices Control Group
Identifying patients with a score of  5 on the anxiety, depression or 
somatoform scale on the PHQ-D 
20 Primary Care Practices Participate
Up to 25 patients potentially 
eligible
Up to 25 patients potentially 
eligible
17 patients in collaborative care 
by an APN, 8 patients reject
17 patients in usual care by their 
GP, 8 patients reject
11 patients in collaborative care 
by an APN, 6 dropouts
11 patients in usual care by their 
GP, 6 dropouts
Follow-Up 1 - 8 weeks post-baseline
Follow-Up 2 - 12 months post-baseline
500 Primary Care Practices in the City of Hamburg Invited
Baseline Assessment
Randomization
Figure 1 CONSORT flowchart for recruitment of practices and
patients (projected).
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orating with a GP, addressing the psychosocial needs of
ADSom-patients can enhance the patients self-efficacy
(a proxy for self-management) compared to usual care.
Furthermore, we want to know if an APN decreases
patients’ symptom loads and psychosocial burdens, and
increases their quality of life, while reducing health care
utilization. A further assignment of the APN is to imple-
ment case management elements into the primary care
practice. After all, we want to estimate whether cooper-
ation between an APN and a GP does improve health
care services for these patients.
The study is part of “Psychenet - Hamburg Network for
Mental Health” (http://www.psychenet.de/en.html) - a
network in the Hamburg region consisting of more than
60 scientific and medical institutions, counseling centers,
governmental authorities, private companies, health insur-
ances as well as patients’ and relatives’ associations. Its
purpose is to work on testing innovative care models
which aim to make decisive improvements to the preven-
tion, diagnosis and treatment of people with mental ill-
nesses in the region [19].
Methods
Study design
We set up an open label, cluster-randomized controlled
trial. We randomly allocate participating general prac-
tices to either the interventional arm, in which a nurse-
led collaborative care model is implemented, or to the
control arm in which the GP continues his/her usual
routine care treating ADSom-patients.
The APN will work directly in the primary care prac-
tices. All participants will be assessed at baseline, 8
weeks post-baseline and 12 months post-baseline. The
scheduled time for providing services in the interven-
tional primary care practices is 12 months. In the con-
trol practices, the patients obtain the „usual care“ by the
GP. In this arm, the course of the disease and the
utilization of GPs or other professions will be docu-
mented. The interventions will take place in the general
practices, the APNs having an own office at their dis-
posal. The practice and the APN arrange a fixed week-
day on which the nurses work in this particular practice.
Figure 1 illustrates patient flow of the SMADS-study.
Ethics approval
Ethics approval was obtained from the Ethics Committee
of the Hamburg Medical Association in October 2012,
approval number PV4106.
Recruitment of the primary care practices
The city of Hamburg is a large metropolitan area with a
population of 1,8 million. There are about 1000 primary
care practices, about 70% of which are owned and operatedby a single GP and his/her practice assistants, while about
30% are group practices.
The recruitment of the 20 GP-practices (10 in the
interventional arm, 10 in the control arm of the study)
will occur through a letter of invitation mailed out to
500 primary care practices in five districts of Hamburg
city, according to the zip code. If they show interest, the
trial will be introduced in more detail. Practices which
don’t respond at all will be selectively recalled to ask for
the reasons (see Figure 2).Randomization
Participating practices will be randomly allocated to
either arm of the trial. A biometrician (AD), not involved
in the field work, randomly selects the practices for the
treatment- and the control-arms of the study.Modules of the complex, psychosocial intervention
Promoting self-management is the target of the planned
complex intervention. Strategies of self-management sup-
port are based on knowledge and information transfer to in-
crease health literacy and facilitate the development of skills,
as well as promoting the use of available health resources
[12]. Self-management support promotes control and re-
sponsibility, thus strengthening the patients’ confidence in
Letter of information mailed to 
zip-code selected primary care 
practices (N=500) - half of the 




20 practices will decide to 
participate (as planned)
Recall










Figure 2 Planned recruitment of primary care practices.
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toms, as well as their impact on his or her daily life [20].
More explicitly, the aim of any self-management in
psychological complaints is to empower the patient:
 to actively pursue the challenges in dealing with
mental symptoms and syndromes,
 to develop an adequate strategy for dealing with the
negative side effects,
 to set up an appropriate symptom management,
 to use problem solving skills in order to manage
daily life, and
 to support the patients and their families on their way
to become qualified (lay)-experts in their own right, as
well as
 to prevent chronification, thus to contribute to the
prevention of personal dependency and home care [21].
The intervention is comprised of several modules to
engage the patient in better self-management and
self-care (Figure 3):
1) Support in finding psychotherapeutic treatment:
Following the indications for psychotherapeutic
treatment, having the APN explain different options,
support in contacting a therapist,
2) Information about disease: Supporting / extending
explanations of the GP, plus four behaviour-modifying
modules at the disposal of the APN which directly
target the self-management activities of patients
such as:
3) Developing daily activities schedules,
4) Coping with daily hassles,
5) Using problem-solving skills,6) (Re)-engaging in his / her social network, and
community activities, as well as
7) Learning relaxation techniques to enable the
patients to reduce their stress levels on their
own and
8) Supporting the patient in making contact with
community based psychosocial services and
self-help groups.
Every single intervention plan will be customized indi-
vidually for each patient according to the specific needs and
the resources a patient offers. Therefore, an APN’s prior
task is to explore patients’ resources for self-management,
symptom control and self-care. An APN has to gain
information which situations and conflicts may affect
the patients’ exposure to stress the most.
Stimulating resource-oriented behaviour modification
will be assessed using Goal Attainment Scaling [22] – a
measure for a single goal to be attained by the patient,
negotiated and decided upon by both the APN and the
patient. In cooperation with the patient, the APN explores
the motivation for change, gathering goals for the patients
using the SMART-criteria [23]: Specific, Measurable,
Achievable, Realistic/Relevant, Timed. At the end, the
measure allows a comparison between a reference and an
actual value.
Finally, there is the collaborative part of the intervention
as the APN’s work is undertaken in close coordination
with the GP:
 The GP documents which module he or she
recommends for the intervention plan.
 Appointments are made to share information
between GPs and APNs over the course of the
intervention, discussing the progress, and creating
ways to rescale the intervention plan.
 Evaluation: Throughout the intervention, the
process will be evaluated by everyone in the triad:
the patient, the GP, and the APN.
 In the 12-month-follow-up patients, as well as the
GPs, will be interviewed to collect information about
the sustainability of the intervention.
Backing up the collaborative care team are two study
scientists: EP, the study GP and psychotherapist, is preparing
the interventions as well as continuously supporting and
supervising the APNs. The study psychologist (TZ) is
organizing the set-up in the primary care environment,
connecting APNs, GPs and practice staff, as well as
helping to debrief the nurses at times.
Advanced practice nurse
We decided to employ nurses experienced in the mana-
gement of patients with psychiatric symptomatology or
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Figure 3 Modules of the complex intervention.
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in primary care or a bachelor of science in nursing. Closely
monitored by the study-GP, the APNs go through a train-
ing program incorporating written documentation and
practical training, live enactments with simulated patients,
and sitting in on therapy in psychiatric wards or a psycho-
somatic outpatient clinic.
Since we have created the job profile with part-time po-
tential, an APN will need to be quite mobile and flexible.
They are supposed to rotate between up to five different
practices, handling a different working environment and
different working hours every weekday.
Study population and recruitment
The study is conducted in the city of Hamburg. Citywide,
half of the GPs are asked to participate. Additionally, we
will recruit GPs by introducing the project in quality cir-
cles and contacting the Hamburg Association of General
Practitioners. As we build up the APN staff step by step
we include practices in a similar mode. The process of
recruiting practices is ongoing.
Inclusion criteria for practices are:
 Willingness to participate in the study regardless of
randomization to the intervention or control arm,
 One single private room at scheduled times for the
APN to deliver the intervention in a protected
environment, No psychotherapeutic treatment within the practice,
neither by the GP him/herself nor by any other
professional in the practice,
 No participation in other studies of “Psychenet:
Hamburg Network for Mental Health”.
The patient recruitment is based on an assessment
taking place in the practice on a particular screening day.
As the capacity of the APN is limited, and we don’t want
to create waiting lists, it is required to recruit patients into
the study adjusted to the APN’s treating capacity.
The first part of the assessment is done by the GP: All
patients who are seen by the doctor on the screening
day, will be put on a chart and checked for inclusion
criteria.
Eligibility criteria for patients are:
1) PHQ ≥ 5 on the anxiety, depression or somatoform
scale,
2) Age: 18–65 years old,
3) Literacy (German),
4) Fully able to give consent,
5) Sufficient auditory and visual capabilities,
6) Currently no psychotherapeutic treatment.
PHQ-D-assessment
Patients found eligible will be informed about the study.













Patients to be screened
Patients to be enrolled
Patients to follow-up
Figure 4 Recruitment and flow of patients (projected).
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cedures of the study, the selection of participants, the
data collection, processing and storage, as well as possi-
bilities for cancellation. In case these terms are accepted,
the participants will have to sign an informed consent
form to participate in the study. Besides that, patients
have to agree to release their physician of his/her medical
confidentiality allowing the APN and the GP to exchange
information. Patients will be asked to complete the
“Patient Health Questionnaire-D (PHQ-D)” [24] and other
instruments introduced later in this paper.
The target population for the intervention are adults
aged 18 to 65 scoring ≥5 on any of the three symptom
scales that are incorporated in the PHQ-D: Anxiety,
using the seven items of the General Anxiety Disorder-
Scale (GAD-7); Depression, using the nine items of the
PHQ-9 depression scale; or somatoform symptoms
which are checked by the fifteen-item somatization scale
of the PHQ, PHQ-15.
Psychiatric symptoms fluctuate on a daily basis and
overlap between the disorders [8]. Thus, we expect many
patients to score above the cut-off on any of the scales. A
score as low as ≥5 to gain access to the counseling service
in the GP practice emphasizes the low-threshold approach
of the intervention. When considering prevention, early
support may impede a chronic condition later on.
Exclusion criteria
We limit the exclusion to the negation of the inclusion
criteria. Also, participation in other studies of our de-
partment will exclude a patient from this study. More-
over, we didn’t enroll terminally ill or immobile patients,
or patients who are not regulars in the practice.
Sample size/power calculation
We calculated a sample size of 220 patients based on an
expected difference between the intervention and the
control group of 2.7 points and a common standard de-
viation of 5.4 points on the General Self-efficacy scale as
the primary outcome 12 months post baseline. assuming
an intra-cluster correlation of 0.05, we will attain a suffi-
cient study power of 80%. For that we need a minimum
of 20 randomized clusters, with an average cluster size
of 11 patients. Assuming a drop-out rate of 33% on the
patient level, we have to recruit 340 patients (on average
17 patients per cluster). The planned numbers and the
patient flow are shown in Figure 4.
Primary outcome measure
The primary outcome measure of the SMADS-study
is self-efficacy. This measure will be assessed by the
General Self-Efficacy Scale (GSE-Scale), [25].
Perceived self efficacy is an important prerequisite for suc-
cessful self-management [26]. The construct, theoreticallyand empirically [20] well founded, was originally developed
by Albert Bandura in the 1970s. Bandura defines self-efficacy
as “people’s beliefs about their capabilities to produce
designated levels of performance that exercise influence over
events that affect their lives” [27]. Based on improved self-
efficacy patients can regain control of their own lives, gaining
new confidence in their ability to perform a task. Yet, as
Battersby et al. wrote, “self-efficacy is not a process; it is an
intermediate outcome or mediator of a patient’s adoption
of self-management behaviours and health behaviour
changes” [28].
The GSE-questionnaire operationalizes the psycho-
logical construct „self efficacy“, consisting of 10 items
ranging from 1 =Not at all true, 2 = Hardly true, 3 =
Moderately true to 4 = Exactly true. The GSE is a valid,
theoretically driven, globally used measurement for the
assessment of self-efficacy and has been translated into 31
languages. The scale measures a general sense of perceived
self-efficacy. It predicts the ability to cope with everyday life,
as well as the ability to adapt after experiencing all kinds of
stressful life events [29].
Study hypotheses
We hypothesize, the APN will improve the self-efficacy
expectations of the patients in the intervention group by
about 2.7 points assuming a common standard deviation
of 5.4 points. A significant increase in this measure
indicates a better ability to perform the broad range of
self-management techniques. A patient who is more
convinced of his or her own chance to have impact on
one’s own life is better prepared to build up resilience
against stressors in life.
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As secondary outcome measures we assess the symptom
load using the PHQ-D. The PHQ-D is a well established
instrument to screen patients for anxious, depressive and
somatoform symptoms. It has good validity and prognos-
tic capabilities [24]. We decided against the use of the
PHQ-D as the primary outcome, even though we use it as
a screening tool to include patients. This is justified by the
supreme goal of the study: Supporting self-management,
measured indirectly, using self-efficacy as a proxy.
In addition, patients will be assessed on their health
related quality of life, answering the EQ-5D question-
naire. The EQ-5D, a 5-item-questionnaire, developed by
the EuroQoL-group (http://www.euroqol.org), is com-
prised of five dimensions: mobility, self-care, usual activ-
ities, pain/discomfort and anxiety/depression. A visual
analogue scale evaluates the patients self-rated health on
a vertical scale where the endpoints are labeled ‘100 -
Best imaginable health state’ and ‘0 - Worst imaginable
health state’. The EQ-5D has satisfying psychometric
properties. There are published reference values for the
general population [30]. Furthermore, coping will be
assessed with the “Coping with Illness scale” [31]. It as-
sesses a broad range of cognitive, behavioural and emo-
tional aspects of coping with an illness. Investigators use
the short version.
Further evaluations include the analyses of cost-
effectiveness, the subsequent number of sickness leaves,
and the utilization of the health care system in the year
post-baseline.
Statistical analyses
For the primary outcome we evaluate the changes in com-
parison to the baseline GSE after 12 months. A linear
mixed model will be calculated for the difference between
the intervention and control groups. The variable “group”
will be considered a fixed effect while the practice will be
considered a random effect under the control of the base-
line covariates (baseline values of GSE and other con-
founders like PHQ-D, age, gender, education, utilization of
the health care system on patient level, as well as age, gen-
der, status of practice (single or group) on practice level.
The two-sided α-level was set to 0.05.
The analyses of the primary outcome will be based on
an intention-to-treat-(ITT)-analysis: All patients enrolled
into the study will be analyzed at follow-up. All drop-
outs not having withdrawn their consent will be asked
again to take part in the final assessment 12-months-
post-baseline. If patients reject this invitation or cannot
be reached at all, their values will be imputed using the
last-observation carried forward (LOCF) method.
The robustness of the results will be investigated per-
forming sensitivity analyses with different methods of
imputing missing values.The same procedures will be applied for the PHQ-D,
the EQ-5D and the „Coping with Illness scale“ as
secondary outcomes. There will also be analyses of
the observed cases (OC). These analyses will include
only those patients, who did not drop out and completed
the final assessment.
Handling of dropouts
We are accounting for 2 different groups of dropouts:
 Patients declaring to abandon the intervention or
repeatedly missing appointments, and
 Patients cancelling their consent, thus, withdraw
from the study.
All dropouts, who will not withdraw their consent will
be contacted again 12 months post-baseline to get a
chance to answer the study questionnaire. Dropouts are
accounted for in the intention-to-treat-analyses.
Methods against bias
Selection bias will be minimized by the randomization of
the practices. The standard recruiting procedure (establish-
ing a screening day in the practice) also tries to keep the
selection bias checked. In order to collect the required data
for a CONSORT flow chart (for clustered trials), the full
recruitment process will be documented.
Public registration
Before starting, the trial was publically registered with an
internet based trial archive, clinicaltrials.gov (NCT01726387).
http://clinicaltrials.gov/show/NCT01726387.
Data monitoring
An independent monitor (Institute for General Practice,
Hannover Medical School) will conduct data monitoring
to ensure high quality data in adherence to the study
protocol. All the paper-pencil-documentation the APNs
produce (memos, process evaluation etc.) will be stored
in the GP-practice and will be made available for the
practice documentation.
Detection bias
Practices in the control arm will have the chance to em-
ploy an APN after finishing the randomized controlled
trial in order to avoid a possible lack of motivation for re-
cruitment and documentation. The APNs will be working
in these practices for another 12 months. Furthermore,
control practices will get the same financial compensation
for their engagement as the GPs in the intervention arm.
Stopping rules
As the planned intervention does not introduce any spe-
cific therapeutic changes but focuses on resources and
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how, patients presenting psychological complaints can
deteriorate – so there is a standardized module imple-
mented to check for suicide risk in patients. The collab-
orative care setting in the GP-practice protects the
patient and the APN in case of an immediate aggrava-
tion. The following stopping rule will be put into action:
If patients’ behaviour threatens the APNs or themselves,
the APN will refer them back to the GP or reject the
intervention in the first place.
Quality assurance and safety
IT, data management and quality assurance will be pro-
vided by the Institute for General Practice, Hannover
Medical School. Quality assurance consists of proce-
dures for the prevention of insufficient data quality, the
detection of inaccurate or incomplete data and actions
to improve data quality, e.g. user training sessions, auto-
matic plausibility and integrity checks within the remote
data entry system and data error reports. In addition, the
study center will regularly receive feedback in the form
of quality reports. In addition a random sample of paper
questionnaires (5%) will be compared with the data en-
tries in the database. Adverse events will be monitored
and reported.
Discussion
This cluster-randomized controlled trial implements a
low threshold, complex, psychosocial intervention for
primary care patients reporting at least moderate symp-
toms of anxiety, depression or somatization. It contains
several innovative features:
 It brings an APN into a GP-practice creating a con-
fidential atmosphere as the patient and his or her
problems, symptoms, and complaints are already
known within the practice.
 It attempts to establish a new professional profile,
the APN, into the German health care system.
 It creates a collaborative care model widely
acknowledged to be beneficial for patients with
psychosocial needs.
 It gains additional knowledge about the needs of
patients who fail to climb some of the high barriers
that lie between them and the access to a
psychosocial service.
 It puts several of the evidence-based principles
for implementing self-management support in
primary care into action that were assembled by
Battersby et al. [28] in their review of reviews
covering 83 meta-analyses. These include brief
targeted assessments, evidence-based information to
guide shared decision-making, the use of a nonjudg-
mental approach, collaborative priority and goalsetting, and collaborative problem solving, just to
name a few.
Also, the trial will offer answers for these questions:
 Is this complex intervention effective in enhancing
self-efficacy, thus empowering the patients to a
better self-management?
 Which beneficial or obstructive conditions go along
with the establishment of a new health professional?
 Eventually, we will be taught by the patients whether
this supplementary health care service supports them
in feeling better off: Is it what they really need?
The study investigates a new type of collaboration
between GPs and APNs for patients with symptoms of
anxiety and depression as well as for patients with somatoform
symptoms in ambulatory care. The objective of the interven-
tion is to empower the patients to enhance self-efficacy and
activate a resource-oriented self-healing process through better
self-management and self-care. We want to examine whether
or not and to what extent collaborative care between a family
doctor and a nurse can mitigate the psychological complaints
of the patients.
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